FCM Travel Solutions has tied up with two partners to offer an end-to-end integrated offering to corporate travellers on the move in this current pandemic.
The TMC has partnered with Fullerton Health to enable corporate travellers to access competitive PCR/Serology test fees, and embarked on a Digital Health Credential programme initiative with Affinidi, a Temasek-backed technology company.
Through the partnership with Fullerton Health, FCM customers will get access to affordable rates for PCR and serology tests that are one of the lowest in the market.
Meanwhile, Affinidi has helped to develop a FCM Travel Portal that will sport a Digital Health Wallet. The wallet is also designed to function as a consolidated traveller profile system which allows FCM customers to display their issued digital health certificates and vaccination results, potentially allowing for faster immigration clearance. Travellers will also have access to a list of accredited healthcare institutions that are able to issue such digital health certificates.
Bertrand Saillet, managing director for FCM Travel Solutions in Asia, said that the collaboration will help its customers use FCM as “a one-stop-shop to not only make flight and accommodation bookings for their trips but also PCR and serology tests”.
Walter Lim, deputy managing director (Singapore), Fullerton Health, added that the company hopes to “play its part at supporting the reopening of economy and at the same time facilitating safe travel”. Moreover, Fullerton has a presence in nine Asia-Pacific markets, making it easier for business travellers to obtain Covid-19 testing.
With specific Covid vaccines recently approved by various countries, travellers who choose to be vaccinated will also be able to include their vaccine status in the portal. The Travel Portal is expected to be launched in January 2021.
